Artia Global Partners LP Argenx Se Transaction History
Artia Global Partners LP
- $416 Billion
- Q2 2025
A detailed history of Artia Global Partners LP transactions in Argenx Se stock. As of the latest transaction made, Artia Global Partners LP holds 78,311 shares of ARGX stock, worth $65 Million. This represents 10.39% of its overall portfolio holdings.
Number of Shares
78,311
Previous 11,311
592.34%
Holding current value
$65 Million
Previous $6.69 Billion
544.8%
% of portfolio
10.39%
Previous 1.69%
Shares
8 transactions
Others Institutions Holding ARGX
# of Institutions
494Shares Held
28.1MCall Options Held
370KPut Options Held
211K-
Price T Rowe Associates Inc Baltimore, MD4.98MShares$4.13 Billion0.31% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$2.31 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.57MShares$2.13 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.95MShares$1.62 Billion0.16% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.18MShares$975 Million11.81% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $45.9B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...